ALT 0 3 0 3 B-clinical_variable
, 3 4 3 4 O
AST 5 8 5 8 B-clinical_variable
, 8 9 8 9 O
total 10 15 10 15 B-clinical_variable
bilirubin 16 25 16 25 I-clinical_variable
, 25 26 25 26 O
or 27 29 27 29 O
alkaline 30 38 30 38 B-clinical_variable
phosphatase 39 50 39 50 I-clinical_variable
> 51 52 51 52 O
1.5 53 56 53 56 B-lower_bound
x 57 58 57 58 I-lower_bound
ULN 59 62 59 62 I-lower_bound

Albumin 0 7 63 70 B-clinical_variable
< 8 9 71 72 O
3.0 10 13 73 76 B-upper_bound
g 14 15 77 78 I-upper_bound
/ 15 16 78 79 I-upper_bound
dL 16 18 79 81 I-upper_bound

Allowed 0 7 82 89 O
concomitant 8 19 90 101 B-treatment
medications 20 31 102 113 I-treatment
will 32 36 114 118 O
include 37 44 119 126 O
mesalamine 45 55 127 137 B-treatment
compounds 56 65 138 147 I-treatment
if 66 68 148 150 O
used 69 73 151 155 O
for 74 77 156 159 O
at 78 80 160 162 O
least 81 86 163 168 O
8 87 88 169 170 B-lower_bound
weeks 89 94 171 176 I-lower_bound
and 95 98 177 180 O
at 99 101 181 183 O
a 102 103 184 185 O
stable 104 110 186 192 O
dose 111 115 193 197 O
for 116 119 198 201 O
at 120 122 202 204 O
least 123 128 205 210 O
4 129 130 211 212 B-lower_bound
weeks 131 136 213 218 I-lower_bound
, 136 137 218 219 O
as 138 140 220 222 O
well 141 145 223 227 O
as 146 148 228 230 O
thiopurines 149 160 231 242 B-treatment
( 161 162 243 244 O
azathioprine 162 174 244 256 B-treatment
, 174 175 256 257 O
6 176 177 258 259 B-treatment
- 177 178 259 260 I-treatment
mercaptopurine 178 192 260 274 I-treatment
) 192 193 274 275 O
if 194 196 276 278 O
used 197 201 279 283 O
at 202 204 284 286 O
a 205 206 287 288 O
stable 207 213 289 295 O
dose 214 218 296 300 O
for 219 222 301 304 O
at 223 225 305 307 O
least 226 231 308 313 O
3 232 233 314 315 B-lower_bound
months 234 240 316 322 I-lower_bound

Concomitant 0 11 323 334 O
major 12 17 335 340 O
comorbidities 18 31 341 354 O
( 32 33 355 356 O
renal 33 38 356 361 B-chronic_disease
, 38 39 361 362 O
hepatic 40 47 363 370 B-chronic_disease
, 47 48 370 371 O
cardiac 49 56 372 379 B-chronic_disease
, 56 57 379 380 O
pulmonary 58 67 381 390 B-chronic_disease
or 68 70 391 393 O
malignancy 71 81 394 404 B-cancer
) 81 82 404 405 O
to 83 85 406 408 O
include 86 93 409 416 O
any 94 97 417 420 O
medical 98 105 421 428 O
conditions 106 116 429 439 O
requiring 117 126 440 449 O
therapeutic 127 138 450 461 B-treatment
anti 139 143 462 466 I-treatment
- 143 144 466 467 I-treatment
coagulation 144 155 467 478 I-treatment
or 156 158 479 481 O
anti 159 163 482 486 B-treatment
- 163 164 486 487 I-treatment
platelet 164 172 487 495 I-treatment
therapy 173 180 496 503 I-treatment

Creatinine 0 10 504 514 B-clinical_variable
or 11 13 515 517 I-clinical_variable
cystatin 14 22 518 526 I-clinical_variable
C 23 24 527 528 I-clinical_variable
> 25 26 529 530 O
ULN 27 30 531 534 O

Diagnosis 0 9 535 544 O
of 10 12 545 547 O
severe 13 19 548 554 B-chronic_disease
UC 20 22 555 557 I-chronic_disease

Evidence 0 8 558 566 O
or 9 11 567 569 O
history 12 19 570 577 O
of 20 22 578 580 O
toxic 23 28 581 586 B-chronic_disease
megacolon 29 38 587 596 I-chronic_disease

Hemoglobin 0 10 597 607 B-clinical_variable
≤ 11 12 608 609 O
10g 13 16 610 613 B-upper_bound
/ 16 17 613 614 I-upper_bound
dL 17 19 614 616 I-upper_bound

Local 0 5 617 622 O
or 6 8 623 625 O
systemic 9 17 626 634 O
complications 18 31 635 648 O
or 32 34 649 651 O
other 35 40 652 657 O
pathological 41 53 658 670 O
states 54 60 671 677 O
requiring 61 70 678 687 O
therapy 71 78 688 695 B-treatment
with 79 83 696 700 I-treatment
corticosteroids 84 99 701 716 I-treatment
and/or 100 106 717 723 O
immunosuppressive 107 124 724 741 B-treatment
agents 125 131 742 748 I-treatment

Male 0 4 749 753 B-gender

Mayo 0 4 754 758 B-clinical_variable
Score 5 10 759 764 I-clinical_variable
> 11 12 765 766 O
10 13 15 767 769 B-lower_bound

Patients 0 8 770 778 O
who 9 12 779 782 O
received 13 21 783 791 O
anti 22 26 792 796 B-treatment
- 26 27 796 797 I-treatment
TNF 27 30 797 800 I-treatment
agents 31 37 801 807 I-treatment
within 38 44 808 814 O
3 45 46 815 816 B-upper_bound
months 47 53 817 823 I-upper_bound
of 54 56 824 826 O
screening 57 66 827 836 O
, 66 67 836 837 O
or 68 70 838 840 O
who 71 74 841 844 O
used 75 79 845 849 O
oral 80 84 850 854 B-treatment
or 85 87 855 857 O
rectal 88 94 858 864 B-treatment
corticosteroids 95 110 865 880 I-treatment
within 111 117 881 887 O
4 118 119 888 889 B-upper_bound
weeks 120 125 890 895 I-upper_bound
of 126 128 896 898 O
screening 129 138 899 908 O

Platelets 0 9 909 918 B-clinical_variable
≤ 10 11 919 920 O
105 12 15 921 924 B-upper_bound

Positive 0 8 925 933 O
stool 9 14 934 939 O
test 15 19 940 944 O
for 20 23 945 948 O
Clostridium 24 35 949 960 B-chronic_disease
difficile 36 45 961 970 I-chronic_disease
, 45 46 970 971 O
ova 47 50 972 975 O
and 51 54 976 979 O
parasites 55 64 980 989 O
, 64 65 989 990 O
or 66 68 991 993 O
routine 69 76 994 1001 O
stool 77 82 1002 1007 O
culture 83 90 1008 1015 O

Potassium 0 9 1016 1025 B-clinical_variable
< 10 11 1026 1027 O
3.0 12 15 1028 1031 B-upper_bound
mmol 16 20 1032 1036 I-upper_bound
/ 20 21 1036 1037 I-upper_bound
L 21 22 1037 1038 I-upper_bound
or 23 25 1039 1041 O
> 26 27 1042 1043 O
5.5 28 31 1044 1047 B-lower_bound
mmol 32 36 1048 1052 I-lower_bound
/ 36 37 1052 1053 I-lower_bound
L 37 38 1053 1054 I-lower_bound

Pregnancy 0 9 1055 1064 B-pregnancy
( 10 11 1065 1066 O
as 11 13 1066 1068 O
confirmed 14 23 1069 1078 O
by 24 26 1079 1081 O
urine 27 32 1082 1087 B-pregnancy
pregnancy 33 42 1088 1097 I-pregnancy
test 43 47 1098 1102 O
at 48 50 1103 1105 O
study 51 56 1106 1111 O
outset 57 63 1112 1118 O
) 63 64 1118 1119 O

Prior 0 5 1120 1125 B-treatment
surgical 6 14 1126 1134 I-treatment
bowel 15 20 1135 1140 I-treatment
resections 21 31 1141 1151 I-treatment

Use 0 3 1152 1155 O
of 4 6 1156 1158 O
known 7 12 1159 1164 O
nephrotoxic 13 24 1165 1176 B-treatment
medications 25 36 1177 1188 I-treatment
( 37 38 1189 1190 O
including 38 47 1190 1199 O
non 48 51 1200 1203 B-treatment
- 51 52 1203 1204 I-treatment
steroidal 52 61 1204 1213 I-treatment
anti 62 66 1214 1218 I-treatment
- 66 67 1218 1219 I-treatment
inflammatory 67 79 1219 1231 I-treatment
drugs 80 85 1232 1237 I-treatment
( 86 87 1238 1239 I-treatment
NSAIDs 87 93 1239 1245 I-treatment
) 93 94 1245 1246 O
, 94 95 1246 1247 O
cyclosporin 96 107 1248 1259 B-treatment
A 108 109 1260 1261 I-treatment
, 109 110 1261 1262 O
tacrolimus 111 121 1263 1273 B-treatment
, 121 122 1273 1274 O
aminoglycoside 123 137 1275 1289 B-treatment
antibiotics 138 149 1290 1301 I-treatment
, 149 150 1301 1302 O
diuretics 151 160 1303 1312 B-treatment
, 160 161 1312 1313 O
angiotensin 162 173 1314 1325 B-treatment
converting 174 184 1326 1336 I-treatment
enzyme 185 191 1337 1343 I-treatment
( 192 193 1344 1345 I-treatment
ACE 193 196 1345 1348 I-treatment
) 196 197 1348 1349 I-treatment
inhibitors 198 208 1350 1360 I-treatment
, 208 209 1360 1361 O
or 210 212 1362 1364 O
angiotensin 213 224 1365 1376 B-treatment
receptor 225 233 1377 1385 I-treatment
blockers 234 242 1386 1394 I-treatment
) 242 243 1394 1395 O
2 244 245 1396 1397 B-upper_bound
weeks 246 251 1398 1403 I-upper_bound
prior 252 257 1404 1409 I-upper_bound
to 258 260 1410 1412 O
or 261 263 1413 1415 O
during 264 270 1416 1422 O
the 271 274 1423 1426 O
study 275 280 1427 1432 O
period 281 287 1433 1439 O

Use 0 3 1440 1443 O
of 4 6 1444 1446 O
over 7 11 1447 1451 O
- 11 12 1451 1452 O
the 12 15 1452 1455 O
- 15 16 1455 1456 O
counter 16 23 1456 1463 O
herbal 24 30 1464 1470 O
or 31 33 1471 1473 O
dietary 34 41 1474 1481 O
supplements 42 53 1482 1493 O
( 54 55 1494 1495 O
excluding 55 64 1495 1504 O
vitamin 65 72 1505 1512 O
and 73 76 1513 1516 O
minerals 77 85 1517 1525 O
) 85 86 1525 1526 O
two 87 90 1527 1530 B-upper_bound
weeks 91 96 1531 1536 I-upper_bound
prior 97 102 1537 1542 I-upper_bound
to 103 105 1543 1545 O
or 106 108 1546 1548 O
during 109 115 1549 1555 O
the 116 119 1556 1559 O
study 120 125 1560 1565 O
period 126 132 1566 1572 O

WBC 0 3 1573 1576 B-clinical_variable
≤ 4 5 1577 1578 O
3000 6 10 1579 1583 B-upper_bound

aged 0 4 1584 1588 B-age
18 5 7 1589 1591 B-lower_bound
- 7 8 1591 1592 O
70 8 10 1592 1594 B-upper_bound
years 11 16 1595 1600 I-upper_bound
old 17 20 1601 1604 O

appendectomy 0 12 1605 1617 B-treatment

female 0 6 1618 1624 B-gender
patients 7 15 1625 1633 I-gender

refusal 0 7 1634 1641 B-contraception_consent
/ 7 8 1641 1642 I-contraception_consent
inability 8 17 1642 1651 I-contraception_consent
to 18 20 1652 1654 I-contraception_consent
use 21 24 1655 1658 I-contraception_consent
effective 25 34 1659 1668 I-contraception_consent
methods 35 42 1669 1676 I-contraception_consent
of 43 45 1677 1679 I-contraception_consent
contraception 46 59 1680 1693 I-contraception_consent
during 60 66 1694 1700 O
the 67 70 1701 1704 O
study 71 76 1705 1710 O
period 77 83 1711 1717 O

stated 0 6 1718 1724 O
desire 7 13 1725 1731 O
to 14 16 1732 1734 O
become 17 23 1735 1741 B-pregnancy
pregnant 24 32 1742 1750 I-pregnancy
during 33 39 1751 1757 O
the 40 43 1758 1761 O
study 44 49 1762 1767 O
period 50 56 1768 1774 O

with 0 4 1775 1779 O
mild- 5 10 1780 1785 O
to 11 13 1786 1788 O
moderately 14 24 1789 1799 O
- 24 25 1799 1800 O
active 25 31 1800 1806 O
UC 32 34 1807 1809 B-chronic_disease
that 35 39 1810 1814 O
extends 40 47 1815 1822 O
at 48 50 1823 1825 O
least 51 56 1826 1831 O
15 57 59 1832 1834 B-lower_bound
cm 60 62 1835 1837 I-lower_bound
proximal 63 71 1838 1846 O
to 72 74 1847 1849 O
the 75 78 1850 1853 O
anal 79 83 1854 1858 O
verge 84 89 1859 1864 O
( 90 91 1865 1866 O
i.e. 91 95 1866 1870 O
not 96 99 1871 1874 O
proctitis 100 109 1875 1884 B-chronic_disease
) 109 110 1884 1885 O
as 111 113 1886 1888 O
defined 114 121 1889 1896 O
by 122 124 1897 1899 O
a 125 126 1900 1901 O
Mayo 127 131 1902 1906 B-clinical_variable
Score 132 137 1907 1912 I-clinical_variable
of 138 140 1913 1915 O
3 141 142 1916 1917 B-lower_bound
- 142 143 1917 1918 O
10 143 145 1918 1920 B-upper_bound
, 145 146 1920 1921 O
with 147 151 1922 1926 O
an 152 154 1927 1929 O
endoscopic 155 165 1930 1940 B-clinical_variable
subscore 166 174 1941 1949 I-clinical_variable
≥ 175 176 1950 1951 O
1 177 178 1952 1953 O

